Maitea Guridi

Maitea Guridi is a Senior Clinical Scientist at Roche, with extensive experience in clinical trials focused on rare diseases such as Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD). With a career spanning over a decade, Maitea has held key positions at leading organizations, including Santhera Pharmaceuticals and academia, where responsibilities encompassed protocol development, data management, and scientific support. Notable achievements include serving as ad interim Clinical Science Leader for DMD gene therapy studies and collaborating on a digital endpoint for clinical trials. Maitea holds multiple degrees, including a PhD in Neurobiology and Neurosciences from the University of Basel, and has a strong research background in genetics and biotechnology.